[Retracted] Prognostic Comparison between cTACE and H101-TACE in Unresectable Hepatocellular Carcinoma (HCC): A Propensity-Score Matching Analysis

Table 4

Tumor responses in two cohorts.

	H101-TACE ()	c-TACE ()
Response			0.025
CR	6 (16.2)	3 (4.1)
PR	17 (45.9)	24 (32.4)
SD	7 (18.9)	17 (23)
PD	7 (18.9)	30 (40.5)
ORR	23 (62.2)	27 (36.5)	0.018
DCR	30 (81.1)	44 (59.5)	0.039

Abbreviations: CR: complete response; PR: partial response; SD: stable disease; PD: progressive disease; ORR: objective response rate; DCR: disease control rate.